Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
71 hedge funds and large institutions have $71.5M invested in Applied Genetic Technologies Corporation in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 7 closing their positions.
1,334% more call options, than puts
Call options by funds: $1.84M | Put options by funds: $128K
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
9% more funds holding
Funds holding: 65 → 71 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $90.6M → $71.5M (-$19.1M)
31% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$2.81M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.43M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$938K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$705K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCPM
Cooper Creek Partners Management
New York
|
-$5.34M |
| 2 |
Millennium Management
New York
|
-$2.12M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.98M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.75M |
| 5 |
Renaissance Technologies
New York
|
-$833K |
AGTC Hedge Fund Activity: Q3 2020 in Review
71 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2020, worth a combined $71.5M — down 21% from $90.6M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AGTC positions and 7 closed out — a net gain of 6 holders — while 18 added to existing stakes and 26 trimmed.
The largest buyer was Portolan Capital Management, adding an estimated $2.81M. The largest seller was Cooper Creek Partners Management, exiting entirely with an estimated $5.34M sold.
- 71 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2020, up from 65 in Q2 2020.
- Funds reported $71.5M of Applied Genetic Technologies Corporation stock for Q3 2020, down 21% quarter-over-quarter.
- 13 funds opened new Applied Genetic Technologies Corporation positions in Q3 2020 and 7 closed out, a net change of +6 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2020 was Portolan Capital Management, an estimated $2.81M added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2020 was Cooper Creek Partners Management, an estimated $5.34M sold.
Based on aggregated 13F filings for Q3 2020.